Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.
about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesReactive Oxygen Species in the Paraventricular Nucleus of the Hypothalamus Alter Sympathetic Activity During Metabolic SyndromeAngiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cellsHyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathwaysUpregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic ratsLosartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans.Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivoRole of the immune system in hypertension: modulation by dietary antioxidants.Regulation of muscle microcirculation in health and diabetes.Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use.Hypertension management and microvascular insulin resistance in diabetesInsulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records.From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance.Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance.Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009The renin angiotensin system and the metabolic syndromeThe effects of the renin-angiotensin-aldosterone system gene polymorphisms on insulin resistance in hypertensive familiesInsulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibitionEffects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin.Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension.Antihypertensive effects of dietary protein and its mechanism.Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionDietary sodium restriction decreases insulin secretion without affecting insulin sensitivity in humansAngiotensin II receptors and drug discovery in cardiovascular disease.Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation.Pharmacological and non-pharmacological interventions to influence adipose tissue function.Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and functionA role for soluble ST2 in vascular remodeling associated with obesity in rats.PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.Angiotensin peptides and central autonomic regulationAKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cellsAngiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wastingAngiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits
P2860
Q26767412-F9974B86-8CE1-4FE9-8E4A-1965D852B60AQ26771514-9DDE52EE-FE10-4237-AD16-7A7AA2383C7FQ28363300-7BF9D603-E407-406B-BDA2-997CED5C0690Q28565051-197D42C4-4B18-48E6-9166-A21FE9A60A56Q28580814-FE8B0866-5BEF-4C0C-A19E-4EF12810DFAFQ29347083-A39D23ED-B99D-418C-8918-3CB69DEA73AAQ30418516-840FD355-1AFB-4C83-9E5D-D3AEE0D1CA1EQ30424204-01CF6F67-E8BF-486A-B5F9-04BF304AF428Q30424339-3728B05F-A2BB-403B-AB69-44B9F855D94FQ30427254-4963C8BC-E7AE-40A0-BF8D-1D2F5ED6FE5EQ30433343-940EF06E-5CD8-4AC8-8C88-776B37D644EDQ30433501-D02D3DC3-D408-483D-B7C3-353AF1896650Q31011189-A4DBCA83-EA9C-4AC8-A262-D6E66CE3AA5BQ31131489-9A93C550-F486-465D-BE17-3609CB7CB7C8Q33539997-B5570A09-3B5E-48D1-A6EC-00E9746E9A6EQ33587148-2D7EE465-0DE9-4F1F-9D64-9E304E36C1D9Q33821236-AC30AFF3-0F43-4FCD-811A-395A11035E2AQ33855046-7577F11A-24F1-4692-B31A-C0C9686DCD37Q33857313-E72D03A3-11F9-4563-91CC-382BD4602822Q33880303-D8CC9EF5-3A07-4937-B546-C86E8B250AF8Q33915412-37B7F749-250A-40CF-87F9-3CC5BB415566Q33951289-E97FF3BD-D358-4156-ACA8-FC08E3209838Q33962150-92589B57-53BB-476A-91BA-3D9FC4F7CDCCQ34163164-546110BB-541C-4ABB-BBFE-090A9EF94CDBQ34166377-4E75C7A9-FDAE-481E-9FCB-DC8964997318Q34175297-62FAAD58-4D46-4E24-9B96-5685B45AF9E1Q34180196-0BBCC2F8-B214-493D-84A8-CAA476A4B91BQ34231611-630ACA93-7A06-4CD1-BE5C-9B0BE90391ABQ34284717-A901FE1E-DD3F-4D7E-92DC-348D9AC60B59Q34496676-F2E03FB0-5F5A-4F6D-80D4-096580D782B9Q34566559-6EB62CBD-0C6B-422E-A1D1-8577AC260F84Q34576535-13237DD6-BD29-4EE0-960E-985977DA2159Q34591369-8BA054A8-7F64-4104-8393-68C2DDBB4070Q35011884-32A1CFCC-C338-490D-81D5-F229A724AEBAQ35050444-A6F73D77-702B-4194-9E30-029E6AC527B6Q35055601-AFA7EE98-00D8-45BC-89A2-18EBE224D2B8Q35059998-8B627125-18CB-40D2-8C00-9884DE5ADBB6Q35131182-0AACD6F1-F352-4716-B6FB-59D70FEC3098Q35240148-E4F7B91C-E088-414E-A4DB-2AB26A99166AQ35448335-1E5B7B8E-D7A1-4F11-980C-F91D218A4517
P2860
Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@en
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@nl
type
label
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@en
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@nl
prefLabel
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@en
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@nl
P2093
P2860
P921
P356
P1476
Angiotensin II inhibits insuli ...... ulin/angiotensin II crosstalk.
@en
P2093
P2860
P304
P356
10.1172/JCI119752
P407
P577
1997-11-01T00:00:00Z